Psychemedics Corporation (PMD)
Market Cap | 17.41M |
Revenue (ttm) | 22.10M |
Net Income (ttm) | -4.15M |
Shares Out | 5.80M |
EPS (ttm) | -0.72 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | $0.14 (4.78%) |
Ex-Dividend Date | May 24, 2023 |
Volume | 14,248 |
Open | 3.000 |
Previous Close | 3.050 |
Day's Range | 2.880 - 3.000 |
52-Week Range | 2.060 - 5.630 |
Beta | 0.67 |
Analysts | n/a |
Price Target | n/a |
Earnings Date | Mar 28, 2024 |
About PMD
Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States and internationally. The company offers screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, and PCP; amphetamines, including ecstasy, eve, and Adderall; opiates, such as heroin, hydrocodone, hydromorphone, oxycodone, oxymorphone, and codeine; synthetic cannabinoids comprising K2, Spice, and Blaze; benzodiazepines consisting of Xanax, Valium, and Ati... [Read more]
Financial Performance
In 2023, Psychemedics's revenue was $22.10 million, a decrease of -12.45% compared to the previous year's $25.24 million. Losses were -$4.15 million, 283.2% more than in 2022.
Financial StatementsNews
Psychemedics Corporation Reports 2023 Financial Results
DALLAS, March 28, 2024 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), the world's leading provider of hair testing for drugs of abuse, announced today financial results for the year ended...
Psychemedics Recognized as a Top 10 Employee Health Testing Services Provider
Dallas, TX, March 21, 2024 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), a global leader in drug testing using hair analysis, is proud to announce its recognition as one of the Top 10 Em...
Psychemedics Corporation Announces Relocation of Headquarters to Dallas, Texas
ACTON, Mass., Jan. 02, 2024 (GLOBE NEWSWIRE) -- Psychemedics Corporation, a global leader in hair testing for drugs of abuse, proudly announces the relocation of its corporate headquarters from Acton,...
Psychemedics Corporation Appoints Daniella Mehalik as VP - Finance
ACTON, Mass., Nov. 27, 2023 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), a global leader in hair testing for substance abuse, proudly announces the appointment of Daniella Mehalik as it...
Psychemedics Corporation Reports Third Quarter 2023 Financial Results
ACTON, Mass., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), a leading provider of hair testing for drugs of abuse, today announced financial results for the third quarter e...
Unveiling the Future of Drug Testing: Psychemedics Introduces Advanced 5-Panel Drug Screen
Psychemedics debuts a 5-panel drug test replacing marijuana with fentanyl, the first hair drug test exclusively targeting the most dire workplace threats.
Psychemedics Corporation Appoints Shannon Shoemaker as Chief Revenue Officer
ACTON, Mass., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Psychemedics Corporation, the world's largest provider of hair testing for drugs of abuse, is pleased to announce the appointment of Shannon Shoemaker ...
Psychemedics Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ACTON, Mass., Aug. 18, 2023 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), the world's largest provider of hair testing for drugs of abuse, announced the grant of inducement awards to its...
Psychemedics Corporation Reports Second Quarter 2023 Financial Results
ACTON, Mass., Aug. 11, 2023 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), the world's largest provider of hair testing for drugs of abuse, today announced financial results for the secon...
Psychemedics Corporation Announces CEO Succession Plan
Brian Hullinger Will Succeed Ray Kubacki as CEO Effective August 17, 2023 Mr. Hullinger Brings 30 Years of Leadership Experience and a Proven Track Record of Driving Growth ACTON, Mass.
Psychemedics Corporation Reports First Quarter 2023 Financial Results and Declares Cash Dividend
ACTON, Mass., May 09, 2023 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), the world's largest provider of hair testing for drugs of abuse, today announced financial results for the first ...
Psychemedics Corporation Reports Fourth Quarter and Full Year 2022 Financial Results and Declares Quarterly Cash Dividend
ACTON, Mass., March 21, 2023 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), the world's largest provider of hair testing for drugs of abuse, announced today fourth quarter and full year f...
Psychemedics Corporation Reports Third Quarter 2022 Financial Results and Declares Quarterly Cash Dividend
ACTON, Mass., Nov. 09, 2022 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), the world's largest provider of hair testing for drugs of abuse, today announced financial results for the third...
Psychemedics Corporation Reports Second Quarter 2022 Financial Results and Declares Quarterly Cash Dividend
ACTON, Mass., Aug. 09, 2022 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), the world's largest provider of hair testing for drugs of abuse, today announced financial results for the secon...
Psychemedics Announces Two New Director Nominees for its 2022 Annual Meeting of Stockholders and Director Walter S. Tomenson, Jr.'s Retirement after More than 20 Years of Dedicated Service
ACTON, Mass., June 09, 2022 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD) announced today that it will be nominating Peter H. Kamin and Darius G. Nevin to serve as new members of its Boar...
Psychemedics Corporation Reports First Quarter 2022 Financial Results and Declares Increased Cash Dividend
ACTON, Mass., May 10, 2022 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), the world's largest provider of hair testing for drugs of abuse, today announced financial results for the first ...
Psychemedics Corporation Reports Fourth Quarter and Full Year 2021 Financial Results
ACTON, Mass., March 29, 2022 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), the world's largest provider of hair testing for drugs of abuse, announced today fourth quarter and full year f...
Psychemedics Corporation Welcomes Drew Reynolds to Its Board of Directors and Announces the Retirement of Harry Connick From His Director Role
ACTON, Mass., March 22, 2022 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD), the world's largest provider of hair testing for drugs of abuse, is pleased to welcome Andrew “Drew” M. Reynolds...
Psychemedics Corporation Declares Cash Dividend
ACTON, Mass., Dec. 10, 2021 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD), the world's largest provider of hair testing for drugs of abuse, today announced that it has declared a cash divi...
Psychemedics Corporation Reports Stronger Revenue, Operating Profit and Earnings Growth in Third Quarter 2021
ACTON, Mass., Nov. 12, 2021 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD), the world's largest provider of hair testing for drugs of abuse, today announced financial results for the third ...
Psychemedics Corporation Reports Stronger Second Quarter 2021 Financial Results
ACTON, Mass., Aug. 10, 2021 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD), the world's largest provider of hair testing for drugs of abuse, today announced financial results for the second...
5 Undervalued Stocks Trading Below the Peter Lynch Value
According to the GuruFocus All-in-One Screener, a Premium feature, as of June 28, the following companies are trading below their Peter Lynch fair values with wide margins of safety and have had posit...
Montana Advisors Writes Open Letter to Psychemedics
MIAMI--(BUSINESS WIRE)---- $PMD--Montana Advisors issues open letter to Psychemedics CEO (Nasdaq: PMD): Dear Kubacki: It was a pleasure speaking with you two months ago via Zoom. I appreciate the time...
Psychemedics Corporation Reports First Quarter 2021 Financial Results
ACTON, Mass., May 10, 2021 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD), the world's largest provider of hair testing for drugs of abuse, today announced financial results for the first q...
Psychemedics Corporation Reports Fourth Quarter and Full Year 2020 Financial Results
ACTON, Mass., March 23, 2021 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD), the world's largest provider of hair testing for drugs of abuse, today announced fourth quarter and full year fi...